Atefeh Helmi Siyasi, Nahid Bijeh, Elham Hakak Dokht, Gholam Rasul Mohammad Rahimi,
Volume 15, Issue 2 (5-2021)
Abstract
Background and Aim: Recent studies indicate that increased body iron stores have been associated with the development of glucose intolerance and type 2 Diabetes. Ferritin is the most important iron storage protein in the body, which is used to evaluate disorders associated with iron metabolism. The aim of this study was to examine the effect of eight weeks of aerobic training on serum ferritin level, glycemic and lipid indices in women with type 2 Diabetes.
Material and Methods: Twenty Diabetic women aged 45-55 years were selected voluntarily and divided into experimental (n=10) and control (n=10) groups. The experimental group participated in the aerobic training program for eight weeks, three 60-minutes sessions per week with an intensity of 55-65% of heart rate reserve. The control group did not participate in any activity during the intervention period. Serum ferritin, glycemic and lipid indices were evaluated before and after eight weeks and then data were analyzed by SPSS software.
Results: Ferritin (P=0.012), insulin (P=0.004), fasting glucose (P=0.041), insulin resistance index (P=0.012), total cholesterol (P=0.041), and triglyceride (P=0.005) significantly decreased, while the mean of HDL(P=0.012) significantly increased in the experimental group. Moreover, the results showed that changes in ferritin (P=0.002), insulin (P=0.014), insulin resistance index (P=0.001) and TG (P=0.010) were statistically significant between the experimental and control groups.
Conclusion: Women with type 2 Diabetes can benefit from moderate-intensity aerobic exercise programs to improve their glycemic and lipid profile, as well as iron metabolism abnormalities.
Nillofar Moradi, Mohammad Azizi, Elham Niromand, Worya Tahmasebi,
Volume 16, Issue 3 (8-2022)
Abstract
Background and Aim: Diabetes is a multifactorial disease characterized by chronic high blood sugar and insulin resistance. In general, the global increase in the incidence of type 2 diabetes is caused by poor nutrition and inactivity. Therefore, the aim of this study was to evaluate the effect of 8 weeks of combined exercise with quinoa supplementation on fasting blood sugar, appetite and quality of life in women with type 2 diabetes.
Materials and Methods: In this study, 36 women with type 2 diabetes were divided into 3 groups: exercise+supplement (n=12), supplement (n=12) and control (n=12). The exercise+supplement and supplement group consumed 25 grams of cooked quinoa seeds for 3 days a week. The exercise+supplement group also did combined exercise for 8 weeks, 3 times a week. Exercise was performed with an intensity of 10-12 pressure perception. The Persian version of the quality-of-life questionnaire was used to measure the quality-of-life index and the appetite questionnaire was used to assess appetite. Blood samples were taken 48 hours before and after the interventions, measurements and questionnaires were completed. One Way ANOVA, LSD post hoc and paired t were used at the significance level of P≤0.05.
Results: According to the results of 8 weeks of intervention in the exercise+supplement group (P=0.001)(2.59%) and the supplement group (P=0.04)(1.54%) compared to the control group (P=0.32)(1.54%) caused a significant reduction in Fasted blood sugar. There was also a significant decrease in appetite index in the exercise+supplement group (P<0.001)(54.20%) and the supplement group (P=0.001)(60.31%) as compared to the control group (P=0.11)(7.91%). Quality of life data also showed a significant increase in this index in the exercise+supplement group (P=0.008)(5.95%) and supplement group (P=0.002)(3.80%) as compared to the control group (P=0.10)(0.99%).
Conclusion: Eight weeks of combined exercise with consumption of quinoa seeds has a positive and improving effect on fasting blood sugar index, quality of life and appetite in patients with type 2 diabetes.
Ali Mawla Gawwam Al Meyyah, Hamid Jaddoa Abbas, Reza Afrisham, Nahid Einollahi,
Volume 17, Issue 4 (10-2023)
Abstract
Background and Aim: Diabetes is a metabolic disorder characterized by an elevated blood glucose level, resulting from impairments in insulin action, insulin secretion, or both; which causes abnormalities in the metabolism of carbohydrates, protein, and lipids. Chronic hyperglycemia is associated with long-term damage, dysfunction, and failure of various organs. Adropin and irisin are newly described proteins that can be an essential component in the pathophysiological pathways of diabetes mellitus. The current study was designed to evaluate Irisin and Adropin biochemical markers in patients with type 2 diabetes mellitus and their correlation with risk factors.
Materials and Methods: A case control study, that included 90 patients of type 2 diabetes mellitus and 90 healthy individuals, who matched for both age and sex with patients. Fasting blood sugar (FBS), HbA1c, serum insulin, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG), irisin and adropin were measured at the chemistry laboratory of AL-Faihaa teaching Hospital by standard methods.
Results: Serum irisin (8.154±1.642 vs. 14.06±3.916 ng/ml) and adropin (25.39±8.897 vs. 59.43±8.768 pg/ml) levels were significantly lower in the patient group than in the control cases, respectively (P.value<0.0001). Serum adropin levels were significantly and positively correlated with age (r=0.236, P=0.025) and negatively with BMI (r=-0.209, P=0.048). While, serum irisin levels were significantly and negatively correlated with TG (r=-0.248, P=0.018). Based on ROC analysis, the AUC for irisin was 0.937 (95% CI: 0.906-0.969), which showed a sensitivity of 91.1% and a specificity of 80.0% at the cut-off of 9.715 (P<0.0001). In addition, the AUC for adropin was 0.991 (95% CI: 0.980-1.00), which showed a sensitivity of 100.0% and a specificity of 91.1% for this biomarker at a cut-off of 37.945 (P<0.0001).
Conclusion: Our findings showed that the serum levels of irisin and adropin were lower in the patient group than in the control group. Probably, the reduction of adropin and irisin may be used as a biomarker to predict the risk of T2DM, which requires more studies in this regard.
